GGrantIndex
← Leaderboards

John Martin Brown

Stanford University

Google Scholar ↗PubMed ↗ORCID ↗
$14,329,263
Attributed
$15,085,811
Total exposure
17
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY2005–15
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$24,678,014 · 19

By mechanism

P01$12,106,417 · 9
R01$9,492,547 · 6
T32$1,895,673 · 1
R44$1,000,000 · 1
R41$179,762 · 1
P41$3,615 · 1

Top collaborators

Others in their field

Top investigators on “Hypoxia”

Research focus

HypoxiaCellsPharmaceutical PreparationsTumorIrradiationRadiation TherapyLeadTirapazamineBaseRadiationSolid NeoplasmLaboratoriesChemotherapyNormal Tissue MorphologyMalignant NeoplasmsResponseSiteAntineoplasticsHead And Neck NeoplasmsBlood VesselsRadiobiologyDoseCell LineOxygen

Grant awards (61)

Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy$484,400
R01 · FY2015 · CA · contact PI
Nanoparticle-based Sensitizer for Radiation Therapy of Glioblastoma$1,000,000
R44 · FY2014 · CA
Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy$471,083
R01 · FY2014 · CA · contact PI
Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy$457,719
R01 · FY2013 · CA · contact PI
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers$494,069
R01 · FY2012 · CA · contact PI
Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy$488,241
R01 · FY2012 · CA · contact PI
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers$495,779
R01 · FY2011 · CA · contact PI
Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy$489,573
R01 · FY2011 · CA · contact PI
Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin$257,723
P01 · FY2011 · CA · contact PI
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers$512,928
R01 · FY2010 · CA · contact PI
Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin$284,462
P01 · FY2010 · CA · contact PI
Experimental Radiotherapy and Chemotherapy With a Potent New Hypoxic Cytotoxin$270,060
R01 · FY2010 · CA · contact PI
Development and Testing of Recombinant Clostridia for Cancer Therapy$179,762
R41 · FY2010 · RR
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers$504,695
R01 · FY2009 · CA · contact PI
Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin$280,878
P01 · FY2009 · CA · contact PI
Experimental Radiotherapy and Chemotherapy With a Potent New Hypoxic Cytotoxin$269,986
R01 · FY2009 · CA · contact PI
Development of New Hypoxic Cytotoxins for Cancer Therapy$1,072,008
P01 · FY2008 · CA · contact PI
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers$506,331
R01 · FY2008 · CA · contact PI
Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin$274,554
P01 · FY2008 · CA · contact PI
Experimental Radiotherapy and Chemotherapy With a Potent New Hypoxic Cytotoxin$269,943
R01 · FY2008 · CA · contact PI
Novel Approaches to Anaerobe-mediated Enzyme Prodrug Therapy$140,471
P01 · FY2008 · CA · contact PI
Development of New Hypoxic Cytotoxins for Cancer Therapy$1,065,709
P01 · FY2007 · CA · contact PI
Yeast Gene Ontology by Phenotypic Profiling$428,491
R01 · FY2007 · GM · contact PI
Experimental Radiotherapy and Chemotherapy With a Potent New Hypoxic Cytotoxin$269,901
R01 · FY2007 · CA · contact PI
Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin$266,819
P01 · FY2007 · CA · contact PI
Novel Approaches to Anaerobe-mediated Enzyme Prodrug Therapy$140,285
P01 · FY2007 · CA · contact PI
Development of New Hypoxic Cytotoxins for Cancer Therapy$1,070,022
P01 · FY2006 · CA · contact PI
Yeast Gene Ontology by Phenotypic Profiling$429,736
R01 · FY2006 · GM · contact PI
Experimental Radiotherapy and Chemotherapy With a Potent New Hypoxic Cytotoxin$277,921
R01 · FY2006 · CA · contact PI
Anaerobe-mediated Enzyme Prodrug Therapy$132,333
P01 · FY2006 · CA · contact PI
Development of New Hypoxic Cytotoxins for Cancer Therapy$1,066,972
P01 · FY2005 · CA
Yeast Gene Ontology by Phenotypic Profiling$441,494
R01 · FY2005 · GM
Anaerobe-mediated Enzyme Prodrug Therapy$129,523
P01 · FY2005 · CA
Development of New Hypoxic Cytotoxins for Cancer Therapy$1,049,012
P01 · FY2004 · CA
Anerobe-Mediated Anticancer Gene Therapy$294,734
R01 · FY2004 · CA
Anaerobe-mediated Enzyme Prodrug Therapy$125,742
P01 · FY2004 · CA
Administrative Core$44,310
P01 · FY2004 · CA
IDENTIFICATION OF PROTEINS THAT INTERACT WITH GENES$3,615
P41 · FY2004 · RR
Anerobe-Mediated Anticancer Gene Therapy$294,673
R01 · FY2003 · CA
DEVELOPMENT OF NEW HYPOXIC CYTOTOXINS FOR CANCER THERAPY$911,733
P01 · FY2002 · CA
Anerobe-Mediated Anticancer Gene Therapy$294,617
R01 · FY2002 · CA
EXPERIMENTAL RADIOTHERAPY--BASIS AND MODIFICATION$250,229
R01 · FY2002 · CA
MECHANISMS OF ACTION OF TRAPAZAMINE$0
P01 · FY2002 · CA
CORE$0
P01 · FY2002 · CA
EFFICACY OF ANALOGS IN VITRO AND IN VIVO$0
P01 · FY2002 · CA
CANCER ETIOLOGY, PREVENTION, DETECTION AND DIAGNOSIS$947,395
T32 · FY2001 · CA
DEVELOPMENT OF NEW HYPOXIC CYTOTOXINS FOR CANCER THERAPY$885,205
P01 · FY2001 · CA
Anerobe-Mediated Anticancer Gene Therapy$297,568
R01 · FY2001 · CA
EXPERIMENTAL RADIOTHERAPY--BASIS AND MODIFICATION$249,994
R01 · FY2001 · CA
CANCER ETIOLOGY, PREVENTION, DETECTION AND DIAGNOSIS$7,854
T32 · FY2001 · CA
CORE$0
P01 · FY2001 · CA
EFFICACY OF ANALOGS IN VITRO AND IN VIVO$0
P01 · FY2001 · CA
MECHANISMS OF ACTION OF TRAPAZAMINE$0
P01 · FY2001 · CA
TUMOR HYPOXIA--MOLECULAR STUDIES &CLINICAL EXPLOITATION$1,584,418
P01 · FY2000 · CA
CANCER ETIOLOGY, PREVENTION, DETECTION AND DIAGNOSIS$940,424
T32 · FY2000 · CA
DEVELOPMENT OF NEW HYPOXIC CYTOTOXINS FOR CANCER THERAPY$887,124
P01 · FY2000 · CA
EXPERIMENTAL RADIOTHERAPY--BASIS AND MODIFICATION$248,382
R01 · FY2000 · CA
CORE--CELL REPOSITORY$218,557
P01 · FY2000 · CA
EXPLOITING TUMOR HYPOXIA--PREDICTING AND TESTING THE OUTCOME$218,557
P01 · FY2000 · CA
EFFICACY OF ANALOGS IN VITRO AND IN VIVO$0
P01 · FY2000 · CA
CORE$0
P01 · FY2000 · CA